51.95 USD
+2.11 (+4.23%)
51.95 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 57 industry peers in the Life Sciences Tools & Services industry. While BRKR is still in line with the averages on profitability rating, there are concerns on its financial health. BRKR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- BRKR had positive earnings in the past year.
- BRKR had a positive operating cash flow in the past year.
- BRKR had positive earnings in each of the past 5 years.
- Each year in the past 5 years BRKR had a positive operating cash flow.
1.2 Ratios
- BRKR has a Return On Assets of -0.37%. This is in the better half of the industry: BRKR outperforms 64.91% of its industry peers.
- BRKR's Return On Equity of -0.97% is fine compared to the rest of the industry. BRKR outperforms 64.91% of its industry peers.
- The Return On Invested Capital of BRKR (4.01%) is better than 68.42% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 13.75%.
- The last Return On Invested Capital (4.01%) for BRKR is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
- In the last couple of years the Profit Margin of BRKR has declined.
- BRKR has a better Operating Margin (8.99%) than 66.67% of its industry peers.
- BRKR's Operating Margin has declined in the last couple of years.
- BRKR has a Gross Margin (48.00%) which is in line with its industry peers.
- BRKR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
- The number of shares outstanding for BRKR has been increased compared to 1 year ago.
- Compared to 5 years ago, BRKR has less shares outstanding
- BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.54 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
- BRKR's Altman-Z score of 2.54 is in line compared to the rest of the industry. BRKR outperforms 59.65% of its industry peers.
- BRKR has a Debt/Equity ratio of 0.82. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
- The Debt to Equity ratio of BRKR (0.82) is worse than 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.54 |
ROIC/WACC0.39
WACC10.36%
2.3 Liquidity
- BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
- BRKR's Current ratio of 1.85 is on the low side compared to the rest of the industry. BRKR is outperformed by 61.40% of its industry peers.
- A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.89, BRKR is doing worse than 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
- BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
- Measured over the past years, BRKR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
- BRKR shows a small growth in Revenue. In the last year, the Revenue has grown by 6.10%.
- BRKR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
- The Earnings Per Share is expected to grow by 5.58% on average over the next years.
- The Revenue is expected to grow by 3.38% on average over the next years.
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue Next Year1.93%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 25.98, which means the current valuation is very expensive for BRKR.
- Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 80.70% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of BRKR to the average of the S&P500 Index (27.32), we can say BRKR is valued inline with the index average.
- BRKR is valuated rather expensively with a Price/Forward Earnings ratio of 23.83.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 80.70% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of BRKR to the average of the S&P500 Index (24.30), we can say BRKR is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.98 | ||
| Fwd PE | 23.83 |
4.2 Price Multiples
- 84.21% of the companies in the same industry are more expensive than BRKR, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.72 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.9
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
5. Dividend
5.1 Amount
- BRKR has a yearly dividend return of 0.40%, which is pretty low.
- BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.09. BRKR pays more dividend than 89.47% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.86, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
- The dividend of BRKR has a limited annual growth rate of 4.81%.
- BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
- As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
- The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
- The dividend of BRKR is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
51.95
+2.11 (+4.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners90.2%
Inst Owner Change-0.22%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap7.89B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts79.09
Price Target54.2 (4.33%)
Short Float %10.27%
Short Ratio4.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)14.21%
PT rev (3m)18.46%
EPS NQ rev (1m)-0.61%
EPS NQ rev (3m)-24.43%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.98 | ||
| Fwd PE | 23.83 | ||
| P/S | 2.3 | ||
| P/FCF | N/A | ||
| P/OCF | 83.7 | ||
| P/B | 3.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.72 |
EPS(TTM)2
EY3.85%
EPS(NY)2.18
Fwd EY4.2%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.19%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.9
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.54 |
F-Score5
WACC10.36%
ROIC/WACC0.39
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.93%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year9.99%
EBIT Next 3Y11.38%
EBIT Next 5Y10.68%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status for BRKR stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for BRKR stock?
The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 25.98 and the Price/Book (PB) ratio is 3.25.
What is the financial health of BRUKER CORP (BRKR) stock?
The financial health rating of BRUKER CORP (BRKR) is 2 / 10.